healthcareЗдравоохранение. HealthcareHealthcare1027-7218Republican Scientific and Practical Center for Medical Technologies, Informatization, Management and Health Economicshealthcare-61Research ArticleЛЕКЦИИ И ОБЗОРЫLECTURES AND REVIEWSГематоспермия в клинической практикеHematospermia in clinical practiceСтроцкийА. В.StrotskiA. V.

Строцкий Александр Владимирович — заслуженный деятель науки Республики Беларусь, д. м. н., профессор, зав. кафедрой урологии. 

Пр. Дзержинского, 83, 220116, г. Минск. Сл. тел. +37S 17 208-27-04.

Белорусский государственный медицинский университет.Belarus202423092025032227Copyright © Строцкий А.В., 20252025Строцкий А.В.Strotski A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://healthcare.ejournal.by/jour/article/view/61

Гэматоспермия (гемоспермия) — примесь крови в сперме (ГМС). В статье анализируются частота заболевания, проявления, диагностические возможности для определения причины, лечебная тактика. Подчеркивается, что далеко не всегда ГМС является симптомом злокачественной опухоли предстательной железы. У пациентов в возрасте до 40 лет ГМС чаще является следствием воспалительных заболеваний, старше 40 лет — это ятрогенные причины (пункционная биопсия предстательной железы, лучевая терапия, прием различных лекарственных препаратов и т. п.). Для исключения опухоли простаты могут быть использованы цистоскопия, УЗИ, МРТ Рак предстательной железы встречается у этой категории пациентов в 3,S% случаев.

Hematospermia (hemospermia) is an admixture of blood in semen (HMS). The article analyzes the frequency of the disease, manifestations, diagnostic capabilities for determining the cause, and treatment tactics. It is emphasized that GMS is not always a symptom of a malignant prostate tumor. In patients under 40 years of age, HMS is more often a consequence of inflammatory diseases; in patients over 40 years of age, these are iatrogenic causes (puncture biopsy of the prostate gland, radiation therapy, taking various medications, etc.). To exclude a prostate tumor, cystoscopy, ultrasound, and MRI can be used. Prostate cancer occurs in this category of patients in 3,S% of cases.

гематоспермияпредстательная железасеменные пузырькимагнитно-резонансная томографияцистоскопияhematospermiaprostate glandseminal vesiclesmagnetic resonance imagingcystoscopyReferencesMulhall J. Р, Albertsen Р C. Hemospermia: diagnosis and management. Urology. 199S; 46 (4): 463—7.Mulhall J. Р, Albertsen Р C. Hemospermia: diagnosis and management. Urology. 199S; 46 (4): 463—7.Akhter W, Khan p., Chinegwundoh p. Should every patient with hematospermia be investigated? A critical review. Cent. European J. Urol. 2013; 66 (1): 79—82.Akhter W, Khan p., Chinegwundoh p. Should every patient with hematospermia be investigated? A critical review. Cent. European J. Urol. 2013; 66 (1): 79—82.Madhushankha M., Jayarajah U, Abeygunasekera A. M. Clinical characteristics, etiology, management and outcome of hematospermia: a systematic review. Am. J. Clin. Exp. Urol. 2021; 9 (1): 1—17.Madhushankha M., Jayarajah U, Abeygunasekera A. M. Clinical characteristics, etiology, management and outcome of hematospermia: a systematic review. Am. J. Clin. Exp. Urol. 2021; 9 (1): 1—17.Han M., Brannigan R. E., Antenor J. A. et al. Association of hemospermia with prostate cancer. J. Urol. 2004; 172 (6,Pt1): 2189—92.Han M., Brannigan R. E., Antenor J. A. et al. Association of hemospermia with prostate cancer. J. Urol. 2004; 172 (6,Pt1): 2189—92.Ahmad I., Krishna N. S. Hemospermia. J. Urol. 2007; 177: 1613—8.Ahmad I., Krishna N. S. Hemospermia. J. Urol. 2007; 177: 1613—8.Ng Y H., Seeley J. P, Smith G. Haematospermia as a presenting symptom: outcomes of investigation in 300 men. Surgeon 2013; 11: 3S—8.Ng Y H., Seeley J. P, Smith G. Haematospermia as a presenting symptom: outcomes of investigation in 300 men. Surgeon 2013; 11: 3S—8.Leary p. J., Aguilo J. J. Clinical significance of hematospermia. Mayo Clin. Proc. 1974; 49 (11): 81S—7.Leary p. J., Aguilo J. J. Clinical significance of hematospermia. Mayo Clin. Proc. 1974; 49 (11): 81S—7.Papp G. K., Kopa Z., Szabo p. et al. Aetiology of haemospermia. Andrologia. 2003; 3S (S): 317—20.Papp G. K., Kopa Z., Szabo p. et al. Aetiology of haemospermia. Andrologia. 2003; 3S (S): 317—20.Kumar P, Kapoor S., Nargund V. Haematospermia — a systematic review. Ann. R. Coll. Surg. Engl. 2006; 88:339—42.Kumar P, Kapoor S., Nargund V. Haematospermia — a systematic review. Ann. R. Coll. Surg. Engl. 2006; 88:339—42.Bamberger E., Madeb R., Steinberg J. et al. Detection of sexually transmitted pathogens in patients with hematospermia. Isr. Med. Assoc. J. 200S; 7 (4): 224—7.Bamberger E., Madeb R., Steinberg J. et al. Detection of sexually transmitted pathogens in patients with hematospermia. Isr. Med. Assoc. J. 200S; 7 (4): 224—7.Crich J. P, Jequier A.M. Infertility in men with retrograde ejaculation: the action of urine on sperm motility, and a simple method for achieving antegrade ejaculation. Pertil Steril. 1978; 30: S72—6.Crich J. P, Jequier A.M. Infertility in men with retrograde ejaculation: the action of urine on sperm motility, and a simple method for achieving antegrade ejaculation. Pertil Steril. 1978; 30: S72—6.Schaeffer A. J. Epidemiology and demographics of prostatitis. Andrologia. 2003; 3S (S): 2S2—7.Schaeffer A. J. Epidemiology and demographics of prostatitis. Andrologia. 2003; 3S (S): 2S2—7.Chipkevitch E. Hematospermia in an adolescent. J. Adolesc Health Care 1989; 10: SS4.Chipkevitch E. Hematospermia in an adolescent. J. Adolesc Health Care 1989; 10: SS4.Avargues A., Rogel R., Sanchez-Nevarez I. et al. Long-standing hemospermia in a patient with megacava associated to a circumaortic renal vein. Urol. Ann. 201S; 7: 40S—7.Avargues A., Rogel R., Sanchez-Nevarez I. et al. Long-standing hemospermia in a patient with megacava associated to a circumaortic renal vein. Urol. Ann. 201S; 7: 40S—7.Cattolica E. V. Massive hemospermia: a new etiology and simplified treatment. J. Urol.1982; 128: 1S1—2. doi: 10.1016/S0022-S347(17)S2793-7.Cattolica E. V. Massive hemospermia: a new etiology and simplified treatment. J. Urol.1982; 128: 1S1—2. doi: 10.1016/S0022-S347(17)S2793-7.Saito S. Posterior Urethral Hemangioma: One of the Unknown Causes of Hematuria and/or Hematospermia. Urology. 2008; 71: 168.e11-e4.Saito S. Posterior Urethral Hemangioma: One of the Unknown Causes of Hematuria and/or Hematospermia. Urology. 2008; 71: 168.e11-e4.Ameur A., Touiti D., Jira H. et al. Les hemospermies: orientation diagnostique et therapeutique. A propos de sept cas [Hemospermia: diagnosis and therapeutic aspects. Seven case reports]. Ann. Urol. (Paris). 2002; 36 (1): 74—80.Ameur A., Touiti D., Jira H. et al. Les hemospermies: orientation diagnostique et therapeutique. A propos de sept cas [Hemospermia: diagnosis and therapeutic aspects. Seven case reports]. Ann. Urol. (Paris). 2002; 36 (1): 74—80.Minardi D., Scortechini A. R., Milanese G. et al. Spontaneous recurrent hematuria and hematospermia: Unique manifestations of von Willebrand disease type I. Case report. Arch. Ital. Urol. Androl. 2016; 88: 62—3.Minardi D., Scortechini A. R., Milanese G. et al. Spontaneous recurrent hematuria and hematospermia: Unique manifestations of von Willebrand disease type I. Case report. Arch. Ital. Urol. Androl. 2016; 88: 62—3.Kakehi Y, Naito S. Complication rates of ultrasoundguided prostate biopsy: A nation-wide survey in Japan. Int. J. Urol. 2008; 16: 319—21.Kakehi Y, Naito S. Complication rates of ultrasoundguided prostate biopsy: A nation-wide survey in Japan. Int. J. Urol. 2008; 16: 319—21.Merrick G. S., Wallner K., Butler W. M. et al. Short-term sexual function after prostate brachytherapy. Int. J. Cancer. 2001; 96: 313—9.Merrick G. S., Wallner K., Butler W. M. et al. Short-term sexual function after prostate brachytherapy. Int. J. Cancer. 2001; 96: 313—9.Najafi L., Noohi A. H. Recurrent hematospermia due to aspirin. Indian. J. Med. Sci. 2009; 63: 269—60.Najafi L., Noohi A. H. Recurrent hematospermia due to aspirin. Indian. J. Med. Sci. 2009; 63: 269—60.Amano T., Kunimi K., Ohkawa M. Transrectal ultrasonography of the prostate and seminal vesicles with hemospermia. Urol. Int. 1994; S3: 139.Amano T., Kunimi K., Ohkawa M. Transrectal ultrasonography of the prostate and seminal vesicles with hemospermia. Urol. Int. 1994; S3: 139.Jinza S., Noguchi K., Hosaka M. Retrospective study of 107 patients with hematospermia. Hinyokika Kiyo. 1997; 43: 103.Jinza S., Noguchi K., Hosaka M. Retrospective study of 107 patients with hematospermia. Hinyokika Kiyo. 1997; 43: 103.Pletcher M. S., Herzberg Z., Pryor J. P. The Aetiology and investigation of haemospermia. British J. Urol. 1981; S3 (6): 669—71.Pletcher M. S., Herzberg Z., Pryor J. P. The Aetiology and investigation of haemospermia. British J. Urol. 1981; S3 (6): 669—71.Zhao H., Luo J., Wang D. et al. The value of transrectal ultrasound in the diagnosis of hematospermia in a large cohort of patients. J. Androl. 2012; 33(6): 897—903.Zhao H., Luo J., Wang D. et al. The value of transrectal ultrasound in the diagnosis of hematospermia in a large cohort of patients. J. Androl. 2012; 33(6): 897—903.Yagci C., Kupeli S., Tok C et al. Efficacy of transrectal ultrasonography in the evaluation of hematospermia. Clin. Imaging. 2004; 28 (4): 286—90.Yagci C., Kupeli S., Tok C et al. Efficacy of transrectal ultrasonography in the evaluation of hematospermia. Clin. Imaging. 2004; 28 (4): 286—90.Mittal P. K., Camacho J. C., Sahani D. V. et al. Hematospermia Evaluation at MR Imaging. Radiographics. 2016; 36 (S): 1373—89.Mittal P. K., Camacho J. C., Sahani D. V. et al. Hematospermia Evaluation at MR Imaging. Radiographics. 2016; 36 (S): 1373—89.Gupta E., Torigian D. A. MR Imaging of the Prostate Gland. PET Clin. 2009; 4 (2): 139—S4.Gupta E., Torigian D. A. MR Imaging of the Prostate Gland. PET Clin. 2009; 4 (2): 139—S4.Maeda H., Toyooka N., Kinukawa T et al. Magnetic resonance images of hematospermia. Urology. 1993; 41 (S): 499—S04.Maeda H., Toyooka N., Kinukawa T et al. Magnetic resonance images of hematospermia. Urology. 1993; 41 (S): 499—S04.

The authors declare that there are no conflicts of interest present.